Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAKT: Capivasertib in ER+ Breast Cancer
NCT02077569Phase 2Completed
- Sponsor
- University of Nottingham
- Start
- Jan 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capivasertib in breast cancer, sponsored by University of Nottingham. Started Jan 2014; status: completed.
02
Drugs
capivasertib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02077569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02077569.